<

INNATE PHARMA (EPA:IPH) French regulatory agency agrees lacutamab TELLOMAK trial can resume recruitment in Sézary syndrome and mycosis fungoides

Transparency directive : regulatory news

13/01/2020 23:00

INNATE PHARMA's latest news


05/04/2024 09:34
19/03/2024 07:00
21/02/2024 07:00
03/11/2023 07:00
29/08/2023 07:00
10/08/2023 07:00
10/06/2023 07:00
12/05/2023 22:00
26/04/2023 22:50
21/04/2023 07:00


Other stories

16/05/2024 07:52
16/05/2024 08:54
16/05/2024 06:02
15/05/2024 20:38
15/05/2024 22:00
16/05/2024 07:02
15/05/2024 22:47
16/05/2024 03:31
16/05/2024 08:05
16/05/2024 07:05
15/05/2024 17:16
16/05/2024 08:51
16/05/2024 02:27
15/05/2024 23:13
16/05/2024 06:00
16/05/2024 08:03
15/05/2024 15:53
16/05/2024 08:00
15/05/2024 20:45
15/05/2024 16:08
15/05/2024 19:40
15/05/2024 19:00
16/05/2024 00:06
16/05/2024 03:00
15/05/2024 22:30
15/05/2024 14:55
16/05/2024 07:30
16/05/2024 08:19
15/05/2024 22:24
15/05/2024 23:29
15/05/2024 11:44
15/05/2024 11:19
15/05/2024 17:00
14/05/2024 23:50
16/05/2024 07:01
16/05/2024 07:00
16/05/2024 08:42
15/05/2024 17:08